Medical device manufacturer CONMED Corporation announced on Monday that it will participate in the annual meeting of the Society of Robotic Surgery taking place this week in Orlando, Florida. The company will demonstrate its latest surgical visualization systems and intelligent stapling technologies at the event and will take part in multiple panel discussions.
CONMED is a leading global supplier of surgical equipment, with a product portfolio spanning arthroscopy, powered instruments, visualization systems, and staplers. In recent years, the company has increased its research and development investment in equipment that complements surgical robotics. Its AirSeal intelligent insufflation system and Edge visualization platform have become key components for multiple robotic surgery systems.
This year's Society of Robotic Surgery annual meeting will focus on topics including the application of artificial intelligence in surgical robotics, the ethics and regulations surrounding remote surgery, and the development progress of next-generation robotic platforms. During the conference, CONMED will host three technical workshops to present case studies on the application of its visualization systems in complex urological and gynecological surgeries.
The Chief Executive Officer of CONMED stated that the surgical robotics market is in a period of rapid growth, but the performance of the robots themselves is heavily dependent on high-quality supporting equipment. The company is collaborating with several surgical robotics developers to provide customized visualization, insufflation, and stapling solutions for different platforms.
According to data from market research firms, the global surgical robotics market size is projected to grow from approximately $12 billion in 2025 to over $25 billion by 2030, representing a compound annual growth rate exceeding 15%. As an upstream supplier of supporting equipment, CONMED is well-positioned to benefit continuously from this expansion.
CONMED is scheduled to release its second-quarter financial results next week. Market expectations are for the company to report quarterly revenue of around $320 million, representing a year-over-year increase of approximately 8%. Buoyed by the conference participation news and the positive industry outlook, CONMED's stock price rose modestly by about 1.5% on Monday on the New York Stock Exchange. The company did not provide specific details regarding product launches or commercial partnerships in its announcement, with more information anticipated to be shared during the conference and in subsequent earnings conference calls.